Bill Text: IL HR0125 | 2023-2024 | 103rd General Assembly | Introduced
Bill Title: Declares May 1 through May 7, 2023 as Tardive Dyskinesia Awareness Week in the State of Illinois. Encourages the citizens of Illinois to become better informed about Tardive Dyskinesia.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Passed) 2023-05-15 - Resolution Adopted [HR0125 Detail]
Download: Illinois-2023-HR0125-Introduced.html
| |||||||
| |||||||
| |||||||
| 1 | HOUSE RESOLUTION
| ||||||
| 2 | WHEREAS, Many people with serious mental health | ||||||
| 3 | conditions, such as bipolar disorder, major depression, | ||||||
| 4 | schizophrenia, and schizoaffective disorder, or | ||||||
| 5 | gastrointestinal disorders, including gastroparesis, nausea, | ||||||
| 6 | and vomiting, may be treated with medications that work as | ||||||
| 7 | dopamine receptor blocking agents (DRBAs), including | ||||||
| 8 | antipsychotics; and
| ||||||
| 9 | WHEREAS, While ongoing treatment with these medications | ||||||
| 10 | can be necessary, prolonged use can also lead to tardive | ||||||
| 11 | dyskinesia (TD), an involuntary movement disorder that is | ||||||
| 12 | characterized by uncontrollable, abnormal, and repetitive | ||||||
| 13 | movements of the face, torso, and/or other body parts; and
| ||||||
| 14 | WHEREAS, It is estimated that TD affects approximately | ||||||
| 15 | 600,000 people in the United States, and approximately 70% of | ||||||
| 16 | people with TD have not been diagnosed, making it important to | ||||||
| 17 | raise awareness about the symptoms and impact of TD because | ||||||
| 18 | even mild symptoms of TD can have physical, social, and | ||||||
| 19 | emotional consequences; and
| ||||||
| 20 | WHEREAS, It is important for people taking DRBA medication | ||||||
| 21 | to be monitored for TD; regular screening for TD in these | ||||||
| 22 | patients is recommended by the American Psychiatric | ||||||
| |||||||
| |||||||
| 1 | Association (APA); and
| ||||||
| 2 | WHEREAS, Clinical research has led to the availability of | ||||||
| 3 | two treatments for adults with TD by the U.S. Food and Drug | ||||||
| 4 | Administration; and
| ||||||
| 5 | WHEREAS, The Legislature can raise awareness of Tardive
| ||||||
| 6 | Dyskinesia in the public and in the medical community; | ||||||
| 7 | therefore, be it
| ||||||
| 8 | RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE ONE | ||||||
| 9 | HUNDRED THIRD GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that | ||||||
| 10 | we declare May 1 through May 7, 2023 as Tardive Dyskinesia | ||||||
| 11 | Awareness Week in the State of Illinois; and be it further
| ||||||
| 12 | RESOLVED, That we encourage the citizens of Illinois to
| ||||||
| 13 | become better informed about Tardive Dyskinesia.
| ||||||
